Mylan launches cholesterol drug

Drug maker announces launch of fenofibrate tablets

PITTSBURGH — Mylan has launched a generic drug for treating cholesterol, the company said Friday.

Mylan announced the launch of fenofibrate tablets in the 48 mg and 145 mg strengths. The drug is used to reduce so-called "bad" low-density lipoprotein cholesterol, total cholesterol, triglycerides and apolipoprotein B while increasing "good" high-density lipoprotein cholesterol in adults with primary hyperocholesterolemia or mixed dyslipidemia.

The drug is a generic version of AbbVie's Tricor. Various versions of the drug had sales of about $1.2 billion during the 12-month period that ended in March 2013, according to IMS Health.


Are you a pharmacy technician working in the retail industry? Find our group on Facebook for more stories like this and join the conversation.

Recommended stories

Login or Register to post a comment.